Two Cases of SARS-CoV-2 Infection in Pediatric Oncohematologic Patients in Spain
Since December 2019, severe acute respiratory syndrome coronavirus 2 infection has spread worldwide. We all are concerned about immunocompromised children, especially hematologic and oncologic pediatric patients. We want to share our experience with 2 pediatric cancer patients with severe acute respiratory syndrome coronavirus 2 infection. Both presented mild disease and good outcome. No respiratory symptoms were identified, but both developed diarrhea, one probably secondary to lopinavir/ritonavir. Pediatric cancer patients may have milder disease than adults, but larger studies are needed to make conclusions.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Immunology and Host Response Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Children | Coronavirus | COVID-19 | Hematology | Infectious Diseases | Kaletra | Norvir | Pediatrics | Respiratory Medicine | SARS | Spain Health | Study